4.0 Dexcel Pharma Technologies Ltd. Large shareholder Transaction date 4 Feb 2020 Notification date 4 Feb 2020 Sale Price 96.54 Quantity 76,636 -5.6% Value US$1,820,056 Comments Filing More details Fewer details
4.0 Dexcel Pharma Technologies Ltd. Large shareholder Transaction date 3 Feb 2020 Notification date 4 Feb 2020 Sale Price 39.68 Quantity 93,988 +6.5% Value US$4,135,858 Comments Filing More details Fewer details
4.0 Dexcel Pharma Technologies Ltd. Large shareholder Transaction date 31 Jan 2020 Notification date 4 Feb 2020 Sale Price 444.56 Quantity 98,759 +28.8% Value US$4,533,548 Comments Filing More details Fewer details
Meckler Jeffrey A ·Chief Executive Officer Executive Director Transaction date 28 Aug 2019 Notification date 29 Aug 2019 Purchase Price 0.68 Quantity 20,000 +11.3% Value US$13,620 Comments Filing More details Fewer details
MADDALUNA ANTHONY J Non-Executive Director Transaction date 27 Aug 2019 Notification date 29 Aug 2019 Purchase Price 0.47 Quantity 25,000 +87.5% Value US$11,750 Filing More details Fewer details
KOZARICH JOHN W Non-Executive Director Transaction date 23 Aug 2019 Notification date 27 Aug 2019 Purchase Price 0.46 Quantity 100,000 +193.2% Value US$45,900 Filing More details Fewer details
Meckler Jeffrey A ·Chief Executive Officer Executive Director Transaction date 23 Aug 2019 Notification date 27 Aug 2019 Purchase Price 0.46 Quantity 100,000 +130.3% Value US$45,700 Filing More details Fewer details